TGFB1 and neoplasm: The TGF-β–Smad pathway is also known to induce production of extracellular matrix component fibronectin [14] and expression of integrin receptors in tumor cells [6], [7], which facilitate cell adhesion and the cell-to-cell interaction of tumor cells with the extracellular matrix of BM-derived stromal cells [15].